Skip to main content

Monia Brett P's Form 4 filing

Ionis Pharmaceuticals Inc (IONS) · filed May 15, 2026

Accession no.
0000874015-26-000185
Filed
May 15, 2026
Trade date
May 13-14, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $356.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Monia Brett PCIK 0001537529Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 13, 2026Common StockMOption exerciseAcquired+1,316$32.60+$42,901.6243,978Direct
May 13, 2026Common StockSSaleDisposed−1,316$78.01−$102,661.16242,662Direct
May 14, 2026Common StockMOption exerciseAcquired+3,220$32.60+$104,972245,882Direct
May 14, 2026Common StockSSaleDisposed−3,220$78.68−$253,349.6242,662Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 13, 2026Common StockMOption exerciseDisposed−1,316$0.00$038,857Direct
May 14, 2026Common StockMOption exerciseDisposed−3,220$0.00$035,637Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)